Julia Aniscenko
Overview
Explore the profile of Julia Aniscenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antunes K, Singanayagam A, Williams L, Faiez T, Farias A, Jackson M, et al.
J Allergy Clin Immunol
. 2022 Oct;
151(2):447-457.e5.
PMID: 36216081
Background: Microbiota are recognized to play a major role in regulation of immunity through release of immunomodulatory metabolites such as short-chain fatty acids (SCFAs). Rhinoviruses (RVs) induce upper respiratory tract...
2.
Singanayagam A, Footitt J, Marczynski M, Radicioni G, Cross M, Finney L, et al.
J Clin Invest
. 2022 Mar;
132(8).
PMID: 35239513
The respiratory tract surface is protected from inhaled pathogens by a secreted layer of mucus rich in mucin glycoproteins. Abnormal mucus accumulation is a cardinal feature of chronic respiratory diseases,...
3.
Farne H, Glanville N, Johnson N, Kebadze T, Aniscenko J, Regis E, et al.
Thorax
. 2021 Oct;
77(10):950-959.
PMID: 34716281
Background And Aims: The chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) antagonist timapiprant improved lung function and asthma control in a phase 2 study, with evidence...
4.
Dhariwal J, Cameron A, Wong E, Paulsen M, Trujillo-Torralbo M, Del Rosario A, et al.
Am J Respir Crit Care Med
. 2021 Sep;
204(11):1259-1273.
PMID: 34469272
Type 2 innate lymphoid cells (ILC2s) are significant sources of type 2 cytokines, which are implicated in the pathogenesis of asthma and asthma exacerbations. The role of ILC2s in virus-induced...
5.
Finney L, Glanville N, Farne H, Aniscenko J, Fenwick P, Kemp S, et al.
J Allergy Clin Immunol
. 2020 Oct;
147(2):510-519.e5.
PMID: 33068560
Background: The mechanisms underlying altered susceptibility and propensity to severe Coronavirus disease 2019 (COVID-19) disease in at-risk groups such as patients with chronic obstructive pulmonary disease (COPD) are poorly understood....
6.
Kamal F, Glanville N, Xia W, Bakhsoliani E, Aniscenko J, Bartlett N, et al.
Chest
. 2020 May;
158(3):947-951.
PMID: 32454043
No abstract available.
7.
Zhu J, Mallia P, Footitt J, Qiu Y, Message S, Kebadze T, et al.
J Allergy Clin Immunol
. 2020 Apr;
146(4):840-850.e7.
PMID: 32283204
Background: Respiratory viral infection causes chronic obstructive pulmonary disease (COPD) exacerbations. We previously reported increased bronchial mucosa eosinophil and neutrophil inflammation in patients with COPD experiencing naturally occurring exacerbations. But...
8.
Calderazzo M, Trujillo-Torralbo M, Finney L, Singanayagam A, Bakhsoliani E, Padmanaban V, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 May;
14:823-832.
PMID: 31114182
COPD patients often do not report acute exacerbations to healthcare providers - unreported exacerbations. It is not known whether variances in symptoms, airway obstruction, aetiology and inflammatory responses account for...
9.
Petrova N, Emelyanova A, Gorbunov E, Edwards M, Walton R, Bartlett N, et al.
Antiviral Res
. 2019 Mar;
164:176.
PMID: 30885298
No abstract available.
10.
Singanayagam A, Glanville N, Girkin J, Ching Y, Marcellini A, Porter J, et al.
Nat Commun
. 2018 Jun;
9(1):2229.
PMID: 29884817
Inhaled corticosteroids (ICS) have limited efficacy in reducing chronic obstructive pulmonary disease (COPD) exacerbations and increase pneumonia risk, through unknown mechanisms. Rhinoviruses precipitate most exacerbations and increase susceptibility to secondary...